Position in ADCT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,226,841
+$293,754 QoQ
Shares Held
860,491
+3.6% QoQ
Ownership
0.677%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $498,843,244 across 54 Drug Manufacturers - Specialty & Generic names. ADCT ranks #20 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,049,626 | $124,076,289 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
3,183,971 | $44,097,998 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
62,008 | $36,769,503 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
647,731 | $31,188,247 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
233,500 | $30,761,290 | |
| 6 | VTRS |
Viatris Inc
|
2,095,093 | $28,304,706 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,111,137 | $26,589,508 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
877,568 | $26,432,348 |
All Filings in ADCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,226,841 | 860,491 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,933,087 | 830,903 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,753,884 | 688,471 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,602,082 | 597,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $975,829 | 692,078 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,426,169 | 716,668 | Shares | Defined | 2025-02-14 | |
| 2022-09-30 | $3,499 | 726 | Shares | Defined | 2022-11-16 | |
| No filing history on record for this holder in this stock. | ||||||